Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 7, 2013, Pages 1187-1193

  Jain, Lokesh ^a   Sharma, Barjesh Chander ^a   Srivastava, Siddharth ^a   Puri, Sunil Kumar ^a   Sharma, Praveen ^b   Sarin, Shiv ^b  

^a G B PANT HOSPITAL   (India)

^b INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Choline; Glutamine; IL 18; IL 6; Myoinositol

Indexed keywords

AMMONIA; CHOLINE; ENDOTOXIN; GLUTAMINE; INOSITOL; INTERLEUKIN 18; INTERLEUKIN 6; LACTULOSE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CHILD TURCOTTE PUGH SCORE; CONTROLLED STUDY; ENDOTOXIN BLOOD LEVEL; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MINIMAL HEPATIC ENCEPHALOPATHY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPEN STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOMETRIC HEPATIC ENCEPHALOPATHIC SCORE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

EID: 84879453955     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12160     Document Type: Article

References (19)

1. Ferenci P, Lockwood A, Mullen K etal. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
2. Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods. Indian J. Gastroenterol. 2003; 22 (Suppl. 2): S37-41.
3. Das A, Dhiman RK, Saraswat VA etal. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J. Gastroenterol. Hepatol. 2001; 16: 531-535.
4. Groeneweg M, Moerland W, Quero JC etal. Screening of subclinical hepatic encephalopathy. J. Hepatol. 2000; 32: 748-753.
5. Marchesini G, Bianchi G, Amodio P etal. Italian Study Group for Quality of Life in Cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-178.
6. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab. Brain Dis. 2001; 16: 37-41.
7. Watanabe A, Tuchida T, Yata Y etal. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab. Brain Dis. 1995; 10: 239-248.
8. Odeh M, Sabo E, Srugo I, Oliven A. Serum levels of tumor necrosis factor-alpha with of hepatic encephalopathy due to chronic liver failure. Liver Int. 2004; 24: 110-116.
9. Ong JP, Aggarwal A, Krieger D etal. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am. J. Med. 2003; 114: 188-193.
10. Amodio P, Del Piccolo F, Marchetti P etal. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29: 1662-1667.
11. Balata S, Damink SW, Ferguson K etal. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003; 37: 931-939.
12. Plauth M, Egberts EH, Hamster W etal. Long term treatment of latent portosystemic encephalopathy with branched-chain amino acids: a double blind placebo-controlled cross over study. J. Hepatol. 1993; 17: 308-314.
13. Montoliu C, Piedrafita B, Serra MA etal. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J. Clin. Gastroenterol. 2009; 43: 272-279.
14. Odeh M, Edmond S, Issac S. Relationship between TNF alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann. Med. 2005; 37: 603-612.
15. Krabbe KS, Reichenberg A, Yirmiya R etal. Low-dose endotoxemia and human neuropsychological functions. Brain Behav. Immun. 2005; 19: 453-460.
16. Harding D, Brull D, Humphries SE etal. Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study. Pediatr. Res. 2005; 58: 117-120.
17. Duchini A, Govindarajan S, Santucci M etal. Effects of tumor necrosis factor α and intrleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J. Investig. Med. 1996; 44: 474-482.
18. Taylor-Robinson SD, Oatridge A, Hajnal JV etal. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetization transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab. Brain Dis. 1995; 10: 175-182.
19. Geissler A, Lock G, Frund R. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25: 48-54.